Since 1983, The John Douglas French Alzheimer's Foundation has funded some of the most innovative Alzheimer's research. Our research focuses on novel areas—generally not being explored by other organizations—in order to gain new insights and a better understanding of Alzheimer's disease at its most fundamental level. Research of this type is an essential step in identifying high-value pathways to a cure.
New research project to examine the role of microglia—immune cells in the brain—in determining risk for Alzheimer’s disease using cellular reprogramming.
The John Douglas French Alzheimer's Foundation has funded an important new research project under the direction of Justin Ichida, PhD, of the University of Southern California, Department of Stem Cell Biology and Regenerative Medicine.
Bruce L. Miller, MD, Chief Medical Officer of The John Douglas French Alzheimer's Foundation, has been elected to the National Academy of Medicine.
Election to the National Academy of Medicine is one of the highest honors in the fields of health and medicine.
JDFAF has just funded a breakthrough research project integrating the expertise and resources of researchers at three University of California campuses.
The new study employs the latest genomic technologies and holds the potential of gaining important new insights into the role of genetics in the development of Alzheimer’s disease.